Aardvark Therapeutics, Inc.

AARD · Nasdaq · SIC 2834: Pharmaceutical Preparations
26
SEC Filings

Business Summary

1 Item 1A. Risk Factors 40 Item 1B. Unresolved Staff Comments 99 Item 1C. Cybersecurity 99 Item 2. Properties 101 Item 3. Legal Proceedings 101 Item 4. Mine Safety Disclosures 101 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 102 Item 6. [Reserved] 102 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 103 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 113 ...

Next Earnings

Q2 FY2026 — expected 2026-09-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAARDdiscussed_in_filing Cybersecurity
topic_mentionAARDdiscussed_in_filing Cybersecurity
topic_mentionAARDdiscussed_in_filing Cybersecurity
topic_mentionAARDdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001193125-26-119770EDGAR120K words
2025-03-312024-12-310000950170-25-047835EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-280260EDGAR73K words
2025-08-132025-06-300000950170-25-108116EDGAR
2025-05-142025-03-310000950170-25-071560EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001193125-26-120164EDGAR1K words
2026-03-230001193125-26-119727EDGAR
2026-02-270001193125-26-082787EDGAR
2026-02-120001193125-26-047757EDGAR
2026-02-100001193125-26-043764EDGAR
2026-01-120001193125-26-009862EDGAR
2025-12-100001193125-25-314364EDGAR
2025-11-130001193125-25-280235EDGAR
2025-11-060001193125-25-267402EDGAR
2025-11-040001193125-25-264748EDGAR

26 total filings indexed. 11 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001774857
TickerAARD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 655ba9dd20804e49476a79c93a2e996f765dd2c8c4c8770e714b80dc0de350b1
parent: 20110d25f8ffdd5ce72446579f25b301a6c01bd8ca6c9ba04c0a7c93cc288703
content hash: 5d58f3b3568d5562a2998b16ad309322e17f95350f01392d01b84aa4eda8c307
signed: 2026-04-13T04:43:24.388Z
sources: 5 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf